Baker Brothers Advisors - IDERA PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$71,100,000
+84.0%
38,641,462
+111.0%
0.60%
+80.0%
Q4 2017$38,646,000
+68.1%
18,315,802
+77.7%
0.34%
+80.1%
Q3 2017$22,984,000
+29.8%
10,306,757
+0.1%
0.19%
+20.0%
Q2 2017$17,707,000
-30.3%
10,294,970
+0.1%
0.16%
-25.5%
Q1 2017$25,408,000
+64.9%
10,286,483
+0.1%
0.21%
+37.7%
Q4 2016$15,408,000
-14.2%
10,272,314
+46.5%
0.15%
-7.4%
Q3 2016$17,956,000
+67.6%
7,014,015
+0.2%
0.16%
+45.5%
Q2 2016$10,711,000
-22.6%
7,000,977
+0.2%
0.11%
-23.3%
Q1 2016$13,841,000
-35.9%
6,990,189
+0.1%
0.15%
-18.4%
Q4 2015$21,578,000
-7.7%
6,983,107
+0.1%
0.18%
-17.1%
Q3 2015$23,370,000
-9.6%
6,976,162
+0.1%
0.22%
-4.8%
Q2 2015$25,862,000
+0.1%
6,970,902
+0.1%
0.23%
+5.6%
Q1 2015$25,842,000
+259.9%
6,965,432
+327.8%
0.22%
+194.5%
Q4 2014$7,181,000
+93.7%
1,628,172
+0.6%
0.07%
+55.3%
Q3 2014$3,708,000
-20.7%
1,619,258
+0.4%
0.05%
-17.5%
Q2 2014$4,678,000
-28.9%
1,613,0760.0%0.06%
-32.1%
Q1 2014$6,581,000
-55.2%
1,613,076
-49.1%
0.08%
-59.4%
Q4 2013$14,685,000
+43.9%
3,171,765
-45.9%
0.21%
+42.8%
Q3 2013$10,205,000
+246.2%
5,865,000
+30.3%
0.14%
+150.0%
Q2 2013$2,948,0004,500,0000.06%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Broadfin Capital, LLC 3,094,745$9,563,0000.59%
WALL STREET ASSOCIATES 400,000$1,236,0000.35%
Palo Alto Investors LP 1,257,748$3,886,0000.22%
Baker Brothers Advisors 6,983,107$21,578,0000.18%
NATIXIS 3,148,916$9,730,0000.16%
GUARDIAN LIFE INSURANCE CO OF AMERICA 371,759$1,149,0000.12%
MYCIO WEALTH PARTNERS, LLC 200,000$618,0000.11%
HOLLENCREST CAPITAL MANAGEMENT 177,570$549,0000.10%
DRIEHAUS CAPITAL MANAGEMENT LLC 701,815$2,169,0000.07%
CARL DOMINO INC 29,137$90,0000.07%
View complete list of IDERA PHARMACEUTICALS INC shareholders